by The global veterinary infusion pumps market size was estimated at around USD 266.37 million in 2022 and it is projected to hit around USD 542.9 million by 2032, growing at a CAGR of 7.38% from 2023 to 2032. The veterinary infusion pumps market in the United States was accounted for USD 70.7 million in 2022.
Key Pointers
- North America led the market with the highest revenue share of 32% in 2022.
- Asia Pacific region is expected to expand at the highest CAGR of 8.08% from 2023 to 2032.
- By Product Type, the volumetric infusion pumps segment dominated the market with a share of 78% in 2022.
- By Animal Type, the companion animals segment generated the maximum market share of 91% in 2022.
- By Route of Administration, the intravenous segment captured the maximum market share of 91% in 2022.
- By End-use, the veterinary hospitals & clinics segment contributed more than 49% of market share in 2022.
- By Application, the fluid therapy segment dominated the global market with the largest market share of 35% in 2022
- By Application, the nutrition segment is projected to grow at the fastest CAGR of 7.82% from 2023 to 2032.
The veterinary infusion pumps market is witnessing robust growth globally, propelled by the escalating demand for advanced medical equipment in veterinary care. Infusion pumps, a critical component in the delivery of fluids and medications to animals, are becoming increasingly indispensable in various veterinary settings. This overview provides insights into the key aspects influencing the dynamics of the veterinary infusion pumps market.
Market Growth
The growth of the veterinary infusion pumps market is underpinned by several key factors. Firstly, there is a discernible surge in the demand for specialized veterinary care, prompting an increased adoption of advanced medical equipment. Veterinary infusion pumps, playing a pivotal role in delivering precise medications and fluids to animals, are witnessing heightened utilization in both companion and livestock healthcare. Furthermore, ongoing technological advancements contribute to the market’s expansion, with the development of smart infusion pumps featuring programmable rates and remote monitoring capabilities. The prevalence of chronic diseases in animals is another significant growth factor, necessitating the continuous and controlled administration of medications facilitated by these infusion pumps. Additionally, the growing financial commitment from pet owners and livestock farmers to invest in advanced veterinary healthcare significantly contributes to the overall market growth. The availability of diverse infusion pump options tailored to different animal sizes and medical requirements further propels the market forward. In essence, the convergence of increased demand for specialized care, technological innovation, and a willingness to invest in animal health collectively propels the veterinary infusion pumps market towards sustained growth.
Get a Sample: https://www.visionresearchreports.com/report/sample/41005
Report Scope of the Veterinary Infusion Pumps Market
| Report Coverage | Details |
| Market Revenue by 2032 | USD 542.9 million |
| Growth Rate from 2023 to 2032 | CAGR of 7.38% |
| Revenue Share of North America in 2022 | 32% |
| CAGR of Asia Pacific from 2023 to 2032 | 8.08% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Read More: https://www.heathcareinsights.com/veterinary-scales-market/
Market Dynamics
Drivers
- Increasing Demand for Specialized Veterinary Care: The veterinary infusion pumps market is driven by a rising demand for specialized healthcare for animals, both in companion and livestock settings. This heightened focus on individualized treatment contributes to the adoption of advanced medical equipment, including infusion pumps.
- Technological Advancements and Smart Infusion Pumps: Ongoing technological innovations in the field of veterinary medicine have led to the development of smart infusion pumps. These devices, equipped with features such as programmable infusion rates and remote monitoring capabilities, enhance the precision and efficiency of medication administration, driving their increased adoption.
Restraints
- Challenges in Addressing Cost Constraints: Addressing cost constraints is a complex challenge for market players. Striking a balance between offering cost-effective solutions and maintaining the necessary technological sophistication poses a dilemma. Manufacturers need to explore innovative strategies to make veterinary infusion pumps more financially accessible without compromising on quality and features.
- Dependency on External Factors: The veterinary infusion pumps market is subject to external factors such as economic conditions and regulatory frameworks. Economic downturns or stringent regulations can impact purchasing decisions, leading to fluctuations in market demand. The market’s susceptibility to external influences poses a challenge for sustained and predictable growth.
Opportunities
- Expansion of Product Portfolios: Manufacturers have the opportunity to expand their product portfolios by introducing infusion pumps tailored to specific animal species and medical requirements. Diversifying product offerings allows companies to address the unique needs of different veterinary practices, enhancing market penetration and catering to a broader range of applications.
- Focus on Education and Professional Awareness: Opportunities lie in initiatives aimed at educating and raising awareness among veterinary professionals regarding the benefits and applications of infusion pumps. Training programs and educational campaigns can bridge the existing knowledge gap, ensuring that veterinary professionals fully understand the advantages of infusion pump technology and use it to its maximum potential.
Product Type Insights
Based on product type, the market is categorized into syringe infusion pumps and volumetric infusion pump segments. The volumetric infusion pumps segment dominated the market with a share of 78% in 2022. This dominance can be attributed to the growing usage of large-volume infusion pumps for numerous benefits, including delivering fluids during animal blood transfusions, parenteral nutrition administration, and emergency conditions. In addition, continuous technological advancements and integration of advanced features for long-term treatments are expected to stimulate segmental growth. Moreover, volumetric infusion pumps offer ergonomic and compact design as well as they are integrated with wireless connectivity for real-time monitoring for effective treatment with better animal care are a few aspects driving segmental demand over the forecast period.
The syringe infusion pumps segment is projected to witness substantial growth in the foreseeable future. The segment demand is primarily attributed to the growing usage of syringe infusion pumps for precise anesthesia administration and drug administration with narrow therapeutic ranges.
Animal Type Insights
Based on animal type, the companion animals segment held the largest market share of over 91% in 2022. The segment growth is due to the significant rise in pet adoption brought on by changing lifestyles, favorable reimbursement coverage, increasing awareness and adoption of advanced veterinary care, and out-of-pocket expenditure among developing economies. For instance, the APPA National Pet Owners Survey estimated that in 2023, around 66% of households own a pet in the U.S. and over 53% in the UK. Thus, increasing pet population in developed regions leads to a risk of several diseases among companion animals, thereby accelerating market demand. Furthermore, an upsurge in pet care spending and heightened awareness among pet owners and veterinarians regarding infusion therapy for critical care are other factors driving segmental demand.
The livestock animals segment held a considerable revenue share in 2022 and is estimated to witness a similar trend over the forecast timeline. The high segment growth potential is owing to increasing awareness regarding infusion therapy for better animal care. Further, the growing adoption of infusion pumps among homecare settings for long-term care broadens overall segmental revenue growth potential over the forecast period.
Route of Administration Insights
In terms of route of administration, the intravenous segment held the highest market share of approximately 91% in 2022. The subcutaneous segment is anticipated to grow at the fastest CAGR of 8.82% over the forecast period. The intravenous route offers several advantages, such as direct delivery to the bloodstream, dosage control, and better immune response, making it a widely adopted route of administration in the veterinary infusion pump sector. Moreover, advancements in infusion technology and the integration of several features, including precise drug dosing, wireless connectivity, and relay mode for continuous infusion, among others, propel segmental growth.
The subcutaneous route segment has gained popularity in recent years due to applications such as drug delivery precision and enhanced patient comfort. The rise in awareness regarding advanced infusion pumps and alternative routes of administration, such as subcutaneous routes among healthcare professionals is anticipated to bolster segmental demand in the foreseeable future.
End-use Insights
In terms of end-use, the veterinary hospitals & clinics segment 49% in 2022. Expanding veterinary hospitals and clinics coupled with an increasing number of veterinarians across the globe is anticipated to spur the market demand. The growing advancements in veterinary healthcare infrastructure and integration of advanced equipment, including infusion pumps among clinical settings, will positively influence the market demand. The rising preference for advanced infusion pumps among veterinarians is owing to several benefits such as precise drug dosing, multi-channel dosing, and integration of several modes to enhance effectiveness and patient outcomes.
The home care segment is predicted to witness unprecedented growth over the projected period. This high growth potential is primarily attributed to the upsurge in long-term care, along with increasing awareness regarding infusion therapy for effective nutrition and fluid management for better results. In addition, increasing pet care spending, especially on pet insurance in high-income countries will spur market growth. For instance, the APPA National Pet Owners Survey stated that U.S. pet owners spent more than USD 136.8 million on pet care in 2022. Thus, rising pet care spending coupled with high product awareness is expected to drive market revenue growth in the forthcoming years.
Application Insights
In terms of application, the fluid therapy segment led the global market with the largest market share of 35% in 2022. The growing adoption of infusion pumps for fluid therapy in veterinary medicine to provide precise control over the administration of fluids and medications is enhancing patient care and thereby driving segmental demand. The rising demand for multi-channel infusion pumps that allow for the simultaneous administration of multiple fluids or medications in complex treatment conditions strengthen the market demand. Furthermore, numerous pharmaceutical and biotech companies are proactively involved in R&D activities and clinical trials for novel drug innovations that require continuous fluid therapy to animals for checking effectivity and bioavailability, which can positively influence segment growth potential.
The nutrition segment is projected to grow at the fastest CAGR of 7.82% over the forecast period. The segment growth is attributed to the growing preference for enteral nutrition in pet care, where nutrients are directly delivered into the gastrointestinal tract through infusion pumps. Moreover, nutrition plays a significant role in preventive veterinary care, and veterinary infusion pumps can be used to administer nutritional solutions that assist in maintaining optimal health and prevent certain diseases. Thus, the aforementioned factors propel segment growth.
Regional Insights
Based on region, North America dominated the market with a share of more than 32% in 2022. The regional growth is owing to factors such as the strong presence of major industry players, increasing prevalence of several chronic diseases, and technological advancements. Key companies, including HESKA Corporation, Grady Medical Systems, and Avante Health Solutions, are headquartered in the U.S., thus contributing to the regional share. Moreover, a strong foothold in R&D activities and clinical trials in the region by several life science companies and research institutes is projected to accelerate product demand in the region. Further, heightened product awareness and high pet care spending are a few other factors propelling the North America market over the forecast period.
Asia Pacific region is expected to grow the fastest at over 8.08% over the forecast period. The regional growth is attributed to the evolving healthcare infrastructure, strong presence of local players, and awareness of animal health and fluid management.
Key Companies
- B. Braun Melsungen AG
- Shenzhen Mindray Animal Medical Technology Co., LTD.
- Avante Health Solutions
- Burtons Medical Equipment
- Digicare Biomedical Technology Inc.
- Eitan Medical Ltd.
- Grady Medical Systems
- HESKA Corporation
- Leading Edge Veterinary Equipment
- Millpledge Veterinary
Veterinary Infusion Pumps Market Report Segmentations:
By Product Type
- Volumetric Infusion Pumps
- Syringe Infusion Pumps
By Animal Type
- Companion Animals
- Livestock Animals
By Route of Administration
- Intravenous (IV)
- Subcutaneous
- Epidural Infusion
- Other Route of Administration
By Application
- Fluid Therapy
- Anesthesia
- Pain Management
- Nutrition
- Other Application
By End-use
- Veterinary Hospitals & Clinics
- Home Care
- Research & Academic Institutions
- Other End-use
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/41005
You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308
